NICE may change drug rules for end of life

By Helen Crump2008-11-06T09:00:00

The National Institute for Health and Clinical Excellence wants to apply different rules when deciding whether to recommend expensive drugs for terminally ill patients with rare conditions.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here